After a few months on fat jabs such as Wegovy or Mounjaro, the feeling of suppression can start to wane and weight loss can ...
A multicenter team including Endeavor Health and Eli Lilly found that once-weekly eloralintide produced dose-dependent weight ...
One of the FDA’s potential approvals this month could break an existing monopoly in the treatment space for a rare growth ...
In a small, short duration trial (12 weeks), a new medication called DR10624 reduced triglyceride levels in most patients ...
The approval for HR-SMM was based on data from the phase 3 AQUILA study, which evaluated Darzalex Faspro in adults aged 31 years and older with HR-SMM.
About semaglutide 2.4 mg in metabolic dysfunction-associated steatohepatitis (MASH) ...
Secondary analyses of the ESSENCE trial were presented at the American Association for the Study of Liver Diseases (AASLD), ...
MSD's cancer immunotherapy Keytruda will soon be available as a subcutaneous injection that does away with the need to visit an infusion clinic. Keytruda Qlex (pembrolizumab and berahyaluronidase alfa ...
Panelists discuss how SC delivery enhances patient convenience and health care efficiency in NSCLC treatment.
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the first Phase III (FENhance 2) of ...
News-Medical.Net on MSN
Novel triple receptor agonist shows potent efficacy in lowering high triglycerides
In a small, short duration trial (12 weeks), a new medication called DR10624 reduced triglyceride levels in most patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results